Literature DB >> 21129489

Gray matter alterations related to P300 abnormalities in subjects at high risk for psychosis: longitudinal MRI-EEG study.

Paolo Fusar-Poli1, Nicolas Crossley, James Woolley, Francesco Carletti, Rocio Perez-Iglesias, Matthew Broome, Louise Johns, Paul Tabraham, Elvira Bramon, Philip McGuire.   

Abstract

BACKGROUND: Psychotic disorders are characterized by gray matter and volumetric and electrophysiological abnormalities. The relationship between these factors in the onset of psychotic illness is unclear.
METHODS: Eighty English-native right-handed subjects (39 subjects at ultra high risk for psychosis "ARMS" and 41 healthy volunteers) were scanned with MRI, and studied using EEG during an oddball task. Both assessments were performed at first clinical presentation. The ARMS subjects were then followed clinically, with the MRI and EEG assessments repeated in a subgroup of each sample.
RESULTS: The P300 amplitude at presentation was significantly lower in the ARMS subjects than in controls. At baseline, the ARMS group showed reduced gray matter volume relative to controls in the right superior frontal gyrus, left medial frontal gyrus, left inferior frontal gyrus, right orbital gyrus and right supramarginal gyrus. Transition to psychosis (26%) was associated with reduced gray matter in the right inferior parietal lobule and in the left parahippocampal gyrus. Within the ARMS group, there was a positive correlation between P300 amplitude and gray matter volume in the right supramarginal gyrus. A significant group by P300 by gray matter interaction was detected in the left medial frontal gyrus. Longitudinal assessment revealed progressive gray matter alterations in prefrontal and subcortical areas of the ARMS but no significant changes in P300 amplitude over time.
CONCLUSIONS: P300 abnormalities in the ARMS are related to alterations in regional gray matter volume and represent a correlate of an increased vulnerability to psychosis.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21129489     DOI: 10.1016/j.neuroimage.2010.11.075

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  22 in total

1.  Volumetric abnormalities predating the onset of schizophrenia and affective psychoses: an MRI study in subjects at ultrahigh risk of psychosis.

Authors:  Paola Dazzan; Bridget Soulsby; Andrea Mechelli; Stephen J Wood; Dennis Velakoulis; Lisa J Phillips; Alison R Yung; Xavier Chitnis; Ashleigh Lin; Robin M Murray; Patrick D McGorry; Philip K McGuire; Christos Pantelis
Journal:  Schizophr Bull       Date:  2011-04-25       Impact factor: 9.306

Review 2.  The prodrome and clinical risk for psychotic disorders.

Authors:  Sandra M Goulding; Carrie W Holtzman; Hanan D Trotman; Arthur T Ryan; Allison N Macdonald; Daniel I Shapiro; Joy L Brasfield; Elaine F Walker
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2013-06-18

3.  Hyperactivity of caudate, parahippocampal, and prefrontal regions during working memory in never-medicated persons at clinical high-risk for psychosis.

Authors:  Heidi W Thermenos; Richard J Juelich; Samantha R DiChiara; Raquelle I Mesholam-Gately; Kristen A Woodberry; Joanne Wojcik; Nikos Makris; Matcheri S Keshavan; Susan Whitfield-Gabrieli; Tsung-Ung W Woo; Tracey L Petryshen; Jill M Goldstein; Martha E Shenton; Robert W McCarley; Larry J Seidman
Journal:  Schizophr Res       Date:  2016-03-07       Impact factor: 4.939

4.  Subcortical Brain Volume Abnormalities in Individuals With an At-risk Mental State.

Authors:  Daiki Sasabayashi; Yoichiro Takayanagi; Tsutomu Takahashi; Naoyuki Katagiri; Atsushi Sakuma; Chika Obara; Masahiro Katsura; Naohiro Okada; Shinsuke Koike; Hidenori Yamasue; Mihoko Nakamura; Atsushi Furuichi; Mikio Kido; Yumiko Nishikawa; Kyo Noguchi; Kazunori Matsumoto; Masafumi Mizuno; Kiyoto Kasai; Michio Suzuki
Journal:  Schizophr Bull       Date:  2020-07-08       Impact factor: 9.306

5.  Lack of Evidence for Regional Brain Volume or Cortical Thickness Abnormalities in Youths at Clinical High Risk for Psychosis: Findings From the Longitudinal Youth at Risk Study.

Authors:  Paul Klauser; Juan Zhou; Joseph K W Lim; Joann S Poh; Hui Zheng; Han Ying Tng; Ranga Krishnan; Jimmy Lee; Richard S E Keefe; R Alison Adcock; Stephen J Wood; Alex Fornito; Michael W L Chee
Journal:  Schizophr Bull       Date:  2015-03-04       Impact factor: 9.306

Review 6.  Electroencephalography and Event-Related Potential Biomarkers in Individuals at Clinical High Risk for Psychosis.

Authors:  Holly K Hamilton; Alison K Boos; Daniel H Mathalon
Journal:  Biol Psychiatry       Date:  2020-04-14       Impact factor: 13.382

Review 7.  P300 as an index of transition to psychosis and of remission: Data from a clinical high risk for psychosis study and review of literature.

Authors:  Yingying Tang; Junjie Wang; Tianhong Zhang; Lihua Xu; Zhenying Qian; Huiru Cui; Xiaochen Tang; Huijun Li; Susan Whitfield-Gabrieli; Martha E Shenton; Larry J Seidman; Robert W McCarley; Matcheri S Keshavan; William S Stone; Jijun Wang; Margaret A Niznikiewicz
Journal:  Schizophr Res       Date:  2019-02-25       Impact factor: 4.939

8.  Auditory and Visual Oddball Stimulus Processing Deficits in Schizophrenia and the Psychosis Risk Syndrome: Forecasting Psychosis Risk With P300.

Authors:  Holly K Hamilton; Scott W Woods; Brian J Roach; Katiah Llerena; Thomas H McGlashan; Vinod H Srihari; Judith M Ford; Daniel H Mathalon
Journal:  Schizophr Bull       Date:  2019-09-11       Impact factor: 9.306

9.  Clinical high risk and first episode schizophrenia: auditory event-related potentials.

Authors:  Elisabetta C del Re; Kevin M Spencer; Naoya Oribe; Raquelle I Mesholam-Gately; Jill Goldstein; Martha E Shenton; Tracey Petryshen; Larry J Seidman; Robert W McCarley; Margaret A Niznikiewicz
Journal:  Psychiatry Res       Date:  2014-11-29       Impact factor: 3.222

Review 10.  The relationship of developmental changes in white matter to the onset of psychosis.

Authors:  Katherine H Karlsgodt; Sarah C Jacobson; Marc Seal; Paolo Fusar-Poli
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.